Antenatal Administration of Extracellular Vesicles Derived From Amniotic Fluid Stem Cells Improves Lung Function in Neonatal Rats With Congenital Diaphragmatic Hernia
Abstract
The severity of pulmonary hypoplasia is a main determinant of outcome for babies with congenital diaphragmatic hernia (CDH). Antenatal administration of extracellular vesicles derived from amniotic fluid stem cells (AFSC-EVs) has been shown to rescue morphological features of lung development in the rat nitrofen model of CDH. Herein, we evaluated whether AFSC-EV administration to fetal rats with CDH is associated with neonatal improvement in lung function.
Keywords
Congenital Diaphragmatic HerniaPulmonary HypoplasiaExtracellular VesiclesAmniotic Fluid Stem CellsFetal TherapyNeonatal OutcomesPrenatal InterventionHashtags
#CongenitalDiaphragmaticHernia#FetalTherapy#StemCellResearch#NeonatalCareThis article is published on an external journal. Click below to read the full text.
Read full article ↗How to cite: GlobalCastMD. Antenatal Administration of Extracellular Vesicles Derived From Amniotic Fluid Stem Cells Improves Lung Function in Neonatal Rats With Congenital Diaphragmatic Hernia. GlobalCastMD Medical Library. 2024-02-27. https://origin-library.globalcastmd.com/article/8180
Comments (0)